a549 nonsmall cell lung cancer cells line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC a549 nonsmall cell lung cancer cells line
    (a) Immunocytochemical staining and (b) protein level of EGFR expression in LO2 cells, HeLa cells, and <t>A549</t> cells. Scale bar = 50 µ m. (c) FL images of A549 cells after 4 h of incubation with free ICG, ICG-LPs, GE11-ICG-LPs, and GE11-ICG-LPs with free GE11 peptide or anti-EGFR antibody blocking. DAPI (blue) counterstains cell nuclei. Scale bar = 50 µ m. (d) The semiquantitative analysis of fluorescence intensity in (c) was determined by ‘Image J' software. Data are expressed as mean ± SD ( n = 3). (e) FL images of A549 cells incubated with GE11-CUR/ICG-LPs after laser irradiation (1 W·cm −2 ) for different times. Scale bar = 50 µ m.
    A549 Nonsmall Cell Lung Cancer Cells Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a549 nonsmall cell lung cancer cells line/product/ATCC
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    a549 nonsmall cell lung cancer cells line - by Bioz Stars, 2024-04
    99/100 stars

    Images

    1) Product Images from "GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy"

    Article Title: GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy

    Journal: Bioinorganic Chemistry and Applications

    doi: 10.1155/2021/5534870

    (a) Immunocytochemical staining and (b) protein level of EGFR expression in LO2 cells, HeLa cells, and A549 cells. Scale bar = 50 µ m. (c) FL images of A549 cells after 4 h of incubation with free ICG, ICG-LPs, GE11-ICG-LPs, and GE11-ICG-LPs with free GE11 peptide or anti-EGFR antibody blocking. DAPI (blue) counterstains cell nuclei. Scale bar = 50 µ m. (d) The semiquantitative analysis of fluorescence intensity in (c) was determined by ‘Image J' software. Data are expressed as mean ± SD ( n = 3). (e) FL images of A549 cells incubated with GE11-CUR/ICG-LPs after laser irradiation (1 W·cm −2 ) for different times. Scale bar = 50 µ m.
    Figure Legend Snippet: (a) Immunocytochemical staining and (b) protein level of EGFR expression in LO2 cells, HeLa cells, and A549 cells. Scale bar = 50 µ m. (c) FL images of A549 cells after 4 h of incubation with free ICG, ICG-LPs, GE11-ICG-LPs, and GE11-ICG-LPs with free GE11 peptide or anti-EGFR antibody blocking. DAPI (blue) counterstains cell nuclei. Scale bar = 50 µ m. (d) The semiquantitative analysis of fluorescence intensity in (c) was determined by ‘Image J' software. Data are expressed as mean ± SD ( n = 3). (e) FL images of A549 cells incubated with GE11-CUR/ICG-LPs after laser irradiation (1 W·cm −2 ) for different times. Scale bar = 50 µ m.

    Techniques Used: Staining, Expressing, Incubation, Blocking Assay, Fluorescence, Software, Irradiation

    (a), (b) Cytotoxicity and phototoxicity of free CUR/ICG, CUR/ICG-LPs and GE11-CUR/ICG-LPs under the NIR laser irradiation (808 nm) of 1 W·cm −2 for 5 min at different concentrations on A549 cells after 24 h incubation. (c) Fluorescence images of A549 cells stained with calcein-AM (green) after different treatments. Scale bar = 100 μ m. (d) Synergistic effect of photo- and chemotherapy based on GE11-CUR/ICG-LPs. Cytotoxicity of GE11-ICG-LPs, GE11-CUR-LPs, and GE11-CUR/ICG-LPs with or without laser exposure was performed by MTT assays. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.
    Figure Legend Snippet: (a), (b) Cytotoxicity and phototoxicity of free CUR/ICG, CUR/ICG-LPs and GE11-CUR/ICG-LPs under the NIR laser irradiation (808 nm) of 1 W·cm −2 for 5 min at different concentrations on A549 cells after 24 h incubation. (c) Fluorescence images of A549 cells stained with calcein-AM (green) after different treatments. Scale bar = 100 μ m. (d) Synergistic effect of photo- and chemotherapy based on GE11-CUR/ICG-LPs. Cytotoxicity of GE11-ICG-LPs, GE11-CUR-LPs, and GE11-CUR/ICG-LPs with or without laser exposure was performed by MTT assays. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.

    Techniques Used: Irradiation, Incubation, Fluorescence, Staining

    (a) Effects of IC-GLPs on the caspase-3 activity in A549 cells, data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001. (b) Intracellular ROS detection by the DCFH-DA fluorescence staining. Scale bar = 50 μ m. (c) Cytoskeletal microtubulin (red) expression in A549 cells after different treatments with laser irradiation. DAPI (blue) counterstains cell nuclei. Scale bar = 10 μ m.
    Figure Legend Snippet: (a) Effects of IC-GLPs on the caspase-3 activity in A549 cells, data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001. (b) Intracellular ROS detection by the DCFH-DA fluorescence staining. Scale bar = 50 μ m. (c) Cytoskeletal microtubulin (red) expression in A549 cells after different treatments with laser irradiation. DAPI (blue) counterstains cell nuclei. Scale bar = 10 μ m.

    Techniques Used: Activity Assay, Fluorescence, Staining, Expressing, Irradiation

    (a) Representative western blot and (b) quantification of Bcl-2 and Bax expression in A549 cells following treatment with PBS, free CUR/ICG, CUR/ICG-LPs, and GE11-CUR/ICG-LPs under 808 nm laser irradiation for 5 min. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05 and ∗∗ P < 0.01. (c) Representative western blot and (d) quantification of PI3K, p-PI3K, Akt, and p-Akt expression in A549 cells following different treatments with laser irradiation. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.
    Figure Legend Snippet: (a) Representative western blot and (b) quantification of Bcl-2 and Bax expression in A549 cells following treatment with PBS, free CUR/ICG, CUR/ICG-LPs, and GE11-CUR/ICG-LPs under 808 nm laser irradiation for 5 min. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05 and ∗∗ P < 0.01. (c) Representative western blot and (d) quantification of PI3K, p-PI3K, Akt, and p-Akt expression in A549 cells following different treatments with laser irradiation. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.

    Techniques Used: Western Blot, Expressing, Irradiation

    human nonsmall cell lung cancer cell line a549  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human nonsmall cell lung cancer cell line a549
    Human Nonsmall Cell Lung Cancer Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nonsmall cell lung cancer cell line a549/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human nonsmall cell lung cancer cell line a549 - by Bioz Stars, 2024-04
    86/100 stars

    Images

    a549 nonsmall cell lung cancer cells line  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC a549 nonsmall cell lung cancer cells line
    (a) Immunocytochemical staining and (b) protein level of EGFR expression in LO2 cells, HeLa cells, and <t>A549</t> cells. Scale bar = 50 µ m. (c) FL images of A549 cells after 4 h of incubation with free ICG, ICG-LPs, GE11-ICG-LPs, and GE11-ICG-LPs with free GE11 peptide or anti-EGFR antibody blocking. DAPI (blue) counterstains cell nuclei. Scale bar = 50 µ m. (d) The semiquantitative analysis of fluorescence intensity in (c) was determined by ‘Image J' software. Data are expressed as mean ± SD ( n = 3). (e) FL images of A549 cells incubated with GE11-CUR/ICG-LPs after laser irradiation (1 W·cm −2 ) for different times. Scale bar = 50 µ m.
    A549 Nonsmall Cell Lung Cancer Cells Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a549 nonsmall cell lung cancer cells line/product/ATCC
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    a549 nonsmall cell lung cancer cells line - by Bioz Stars, 2024-04
    99/100 stars

    Images

    1) Product Images from "GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy"

    Article Title: GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy

    Journal: Bioinorganic Chemistry and Applications

    doi: 10.1155/2021/5534870

    (a) Immunocytochemical staining and (b) protein level of EGFR expression in LO2 cells, HeLa cells, and A549 cells. Scale bar = 50 µ m. (c) FL images of A549 cells after 4 h of incubation with free ICG, ICG-LPs, GE11-ICG-LPs, and GE11-ICG-LPs with free GE11 peptide or anti-EGFR antibody blocking. DAPI (blue) counterstains cell nuclei. Scale bar = 50 µ m. (d) The semiquantitative analysis of fluorescence intensity in (c) was determined by ‘Image J' software. Data are expressed as mean ± SD ( n = 3). (e) FL images of A549 cells incubated with GE11-CUR/ICG-LPs after laser irradiation (1 W·cm −2 ) for different times. Scale bar = 50 µ m.
    Figure Legend Snippet: (a) Immunocytochemical staining and (b) protein level of EGFR expression in LO2 cells, HeLa cells, and A549 cells. Scale bar = 50 µ m. (c) FL images of A549 cells after 4 h of incubation with free ICG, ICG-LPs, GE11-ICG-LPs, and GE11-ICG-LPs with free GE11 peptide or anti-EGFR antibody blocking. DAPI (blue) counterstains cell nuclei. Scale bar = 50 µ m. (d) The semiquantitative analysis of fluorescence intensity in (c) was determined by ‘Image J' software. Data are expressed as mean ± SD ( n = 3). (e) FL images of A549 cells incubated with GE11-CUR/ICG-LPs after laser irradiation (1 W·cm −2 ) for different times. Scale bar = 50 µ m.

    Techniques Used: Staining, Expressing, Incubation, Blocking Assay, Fluorescence, Software, Irradiation

    (a), (b) Cytotoxicity and phototoxicity of free CUR/ICG, CUR/ICG-LPs and GE11-CUR/ICG-LPs under the NIR laser irradiation (808 nm) of 1 W·cm −2 for 5 min at different concentrations on A549 cells after 24 h incubation. (c) Fluorescence images of A549 cells stained with calcein-AM (green) after different treatments. Scale bar = 100 μ m. (d) Synergistic effect of photo- and chemotherapy based on GE11-CUR/ICG-LPs. Cytotoxicity of GE11-ICG-LPs, GE11-CUR-LPs, and GE11-CUR/ICG-LPs with or without laser exposure was performed by MTT assays. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.
    Figure Legend Snippet: (a), (b) Cytotoxicity and phototoxicity of free CUR/ICG, CUR/ICG-LPs and GE11-CUR/ICG-LPs under the NIR laser irradiation (808 nm) of 1 W·cm −2 for 5 min at different concentrations on A549 cells after 24 h incubation. (c) Fluorescence images of A549 cells stained with calcein-AM (green) after different treatments. Scale bar = 100 μ m. (d) Synergistic effect of photo- and chemotherapy based on GE11-CUR/ICG-LPs. Cytotoxicity of GE11-ICG-LPs, GE11-CUR-LPs, and GE11-CUR/ICG-LPs with or without laser exposure was performed by MTT assays. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.

    Techniques Used: Irradiation, Incubation, Fluorescence, Staining

    (a) Effects of IC-GLPs on the caspase-3 activity in A549 cells, data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001. (b) Intracellular ROS detection by the DCFH-DA fluorescence staining. Scale bar = 50 μ m. (c) Cytoskeletal microtubulin (red) expression in A549 cells after different treatments with laser irradiation. DAPI (blue) counterstains cell nuclei. Scale bar = 10 μ m.
    Figure Legend Snippet: (a) Effects of IC-GLPs on the caspase-3 activity in A549 cells, data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001. (b) Intracellular ROS detection by the DCFH-DA fluorescence staining. Scale bar = 50 μ m. (c) Cytoskeletal microtubulin (red) expression in A549 cells after different treatments with laser irradiation. DAPI (blue) counterstains cell nuclei. Scale bar = 10 μ m.

    Techniques Used: Activity Assay, Fluorescence, Staining, Expressing, Irradiation

    (a) Representative western blot and (b) quantification of Bcl-2 and Bax expression in A549 cells following treatment with PBS, free CUR/ICG, CUR/ICG-LPs, and GE11-CUR/ICG-LPs under 808 nm laser irradiation for 5 min. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05 and ∗∗ P < 0.01. (c) Representative western blot and (d) quantification of PI3K, p-PI3K, Akt, and p-Akt expression in A549 cells following different treatments with laser irradiation. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.
    Figure Legend Snippet: (a) Representative western blot and (b) quantification of Bcl-2 and Bax expression in A549 cells following treatment with PBS, free CUR/ICG, CUR/ICG-LPs, and GE11-CUR/ICG-LPs under 808 nm laser irradiation for 5 min. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05 and ∗∗ P < 0.01. (c) Representative western blot and (d) quantification of PI3K, p-PI3K, Akt, and p-Akt expression in A549 cells following different treatments with laser irradiation. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.

    Techniques Used: Western Blot, Expressing, Irradiation

    nonsmall cell lung cancer nsclc cell lines a549  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    ATCC nonsmall cell lung cancer nsclc cell lines a549
    Enrichment of CSCs from <t>A549</t> and PC-9 cells. (A) After being cultured in a serum-free medium, spheres derived from A549 and PC-9 were imaged at an amplification of ×10. (B) By performing CCK-8 assay, the cell viability of CSCs and their parental cells from days 1 to 5 was measured. * p < 0.05 vs. the parental cell group. The mRNA (C) and protein levels (D) of stemness hallmarkers, including CD24, CD44, ALDH1, Nanog, Oct4, and Sox2 were measured by performing RT-qPCR and Western blot analysis. * p < 0.05 vs. parental cell group.
    Nonsmall Cell Lung Cancer Nsclc Cell Lines A549, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonsmall cell lung cancer nsclc cell lines a549/product/ATCC
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nonsmall cell lung cancer nsclc cell lines a549 - by Bioz Stars, 2024-04
    93/100 stars

    Images

    1) Product Images from "RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53"

    Article Title: RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53

    Journal: Frontiers in Oncology

    doi: 10.3389/fonc.2022.858694

    Enrichment of CSCs from A549 and PC-9 cells. (A) After being cultured in a serum-free medium, spheres derived from A549 and PC-9 were imaged at an amplification of ×10. (B) By performing CCK-8 assay, the cell viability of CSCs and their parental cells from days 1 to 5 was measured. * p < 0.05 vs. the parental cell group. The mRNA (C) and protein levels (D) of stemness hallmarkers, including CD24, CD44, ALDH1, Nanog, Oct4, and Sox2 were measured by performing RT-qPCR and Western blot analysis. * p < 0.05 vs. parental cell group.
    Figure Legend Snippet: Enrichment of CSCs from A549 and PC-9 cells. (A) After being cultured in a serum-free medium, spheres derived from A549 and PC-9 were imaged at an amplification of ×10. (B) By performing CCK-8 assay, the cell viability of CSCs and their parental cells from days 1 to 5 was measured. * p < 0.05 vs. the parental cell group. The mRNA (C) and protein levels (D) of stemness hallmarkers, including CD24, CD44, ALDH1, Nanog, Oct4, and Sox2 were measured by performing RT-qPCR and Western blot analysis. * p < 0.05 vs. parental cell group.

    Techniques Used: Cell Culture, Derivative Assay, Amplification, CCK-8 Assay, Quantitative RT-PCR, Western Blot

    CSCs present a relatively lower m 6 A methylation level compared with their parental cells. (A) Global m 6 A methylation was measured in CSCs and its parental cells of A549 and PC-9. * p < 0.05 vs. parental cells. m 6 A methylation-relative gene expressions including METLL3, METLL14, YTHDF1, WTAP, FTO, and ALKBH5 were measured in mRNA (B) and protein levels (C) . (D) By employing the GEPIA database analysis tool, the relative mRNA levels of METLL3, METLL14, YTHDF1, WTAP, FTO, and ALKBH5 were compared between tumor samples and nontumor samples.
    Figure Legend Snippet: CSCs present a relatively lower m 6 A methylation level compared with their parental cells. (A) Global m 6 A methylation was measured in CSCs and its parental cells of A549 and PC-9. * p < 0.05 vs. parental cells. m 6 A methylation-relative gene expressions including METLL3, METLL14, YTHDF1, WTAP, FTO, and ALKBH5 were measured in mRNA (B) and protein levels (C) . (D) By employing the GEPIA database analysis tool, the relative mRNA levels of METLL3, METLL14, YTHDF1, WTAP, FTO, and ALKBH5 were compared between tumor samples and nontumor samples.

    Techniques Used: Methylation

    p53 transcriptionally regulates ALKBH5 and subsequently decreased m 6 A methylation. (A) GEPIA database analysis tool was used to compare the correlation between ALKBH5 and p53 in LUAD and LUSC. (B) In A549 and PC-9 CSCs, the efficiency of p53 knockdown or overexpression was measured by performing a Western blot analysis. (C) After modification of p53 with or without PFT-α, ALKBH5 mRNA and protein level were measured. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. p53 group. (D) After modification of p53 with or without PFT-α, m 6 A methylation level was measured. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05, vs. vector group; # p < 0.05 vs. p53 group (right panel).
    Figure Legend Snippet: p53 transcriptionally regulates ALKBH5 and subsequently decreased m 6 A methylation. (A) GEPIA database analysis tool was used to compare the correlation between ALKBH5 and p53 in LUAD and LUSC. (B) In A549 and PC-9 CSCs, the efficiency of p53 knockdown or overexpression was measured by performing a Western blot analysis. (C) After modification of p53 with or without PFT-α, ALKBH5 mRNA and protein level were measured. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. p53 group. (D) After modification of p53 with or without PFT-α, m 6 A methylation level was measured. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05, vs. vector group; # p < 0.05 vs. p53 group (right panel).

    Techniques Used: Methylation, Over Expression, Western Blot, Modification, Plasmid Preparation

    p53 inhibits malignancies via exerting transcriptional activity. In A549 CSCs, p53 was efficiently knockdown by transfecting shRNA targeting to p53 mRNA. In PC-9 CSCs, p53 was efficiently overexpressed by transfecting p53-coding plasmid. Cell viability was then analyzed by performing CCK-8 assay (A) . * p < 0.05 vs. shScrambled group (left panel); * p < 0.05 vs. vector group (right panel). (B) Cell cycle distribution was analyzed by performing PI staining followed by flow cytometry assay. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel). (C) Cell invasion was analyzed by performing Transwell assay. * p <0.05 vs. shScrambled group; # p < 0.05, vs. shp53 group (left panel); * p < 0.05, vs. vector group; # p < 0.05 vs. p53 group (right panel). (D) Tumor formation in soft agar was performed. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel).
    Figure Legend Snippet: p53 inhibits malignancies via exerting transcriptional activity. In A549 CSCs, p53 was efficiently knockdown by transfecting shRNA targeting to p53 mRNA. In PC-9 CSCs, p53 was efficiently overexpressed by transfecting p53-coding plasmid. Cell viability was then analyzed by performing CCK-8 assay (A) . * p < 0.05 vs. shScrambled group (left panel); * p < 0.05 vs. vector group (right panel). (B) Cell cycle distribution was analyzed by performing PI staining followed by flow cytometry assay. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel). (C) Cell invasion was analyzed by performing Transwell assay. * p <0.05 vs. shScrambled group; # p < 0.05, vs. shp53 group (left panel); * p < 0.05, vs. vector group; # p < 0.05 vs. p53 group (right panel). (D) Tumor formation in soft agar was performed. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel).

    Techniques Used: Activity Assay, shRNA, Plasmid Preparation, CCK-8 Assay, Staining, Flow Cytometry, Transwell Assay

    p53 potentially regulates PRRX1, Sox2, and E-cadherin via ALKBH5. In A549 CSCs, p53 was efficiently knockdown by transfecting shRNA targeting p53 mRNA. In PC-9 CSCs, p53 was efficiently overexpressed by transfecting p53-coding plasmid. mRNA (A) and protein (B) of PRRX1, Sox2, and E-cadherin were measured. * p < 0.05 shScrambled group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel).
    Figure Legend Snippet: p53 potentially regulates PRRX1, Sox2, and E-cadherin via ALKBH5. In A549 CSCs, p53 was efficiently knockdown by transfecting shRNA targeting p53 mRNA. In PC-9 CSCs, p53 was efficiently overexpressed by transfecting p53-coding plasmid. mRNA (A) and protein (B) of PRRX1, Sox2, and E-cadherin were measured. * p < 0.05 shScrambled group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel).

    Techniques Used: shRNA, Plasmid Preparation

    human nonsmall cell lung cancer cell lines a549  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human nonsmall cell lung cancer cell lines a549
    Human Nonsmall Cell Lung Cancer Cell Lines A549, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nonsmall cell lung cancer cell lines a549/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human nonsmall cell lung cancer cell lines a549 - by Bioz Stars, 2024-04
    86/100 stars

    Images

    human nonsmall cell lung cancer cell line a549  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC human nonsmall cell lung cancer cell line a549
    Human Nonsmall Cell Lung Cancer Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nonsmall cell lung cancer cell line a549/product/ATCC
    Average 96 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human nonsmall cell lung cancer cell line a549 - by Bioz Stars, 2024-04
    96/100 stars

    Images

    human nonsmall cell lung cancer cell line a549  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human nonsmall cell lung cancer cell line a549
    Human Nonsmall Cell Lung Cancer Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nonsmall cell lung cancer cell line a549/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human nonsmall cell lung cancer cell line a549 - by Bioz Stars, 2024-04
    86/100 stars

    Images

    human nonsmall cell lung cancer a549 cell line  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    ATCC human nonsmall cell lung cancer a549 cell line
    Human Nonsmall Cell Lung Cancer A549 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nonsmall cell lung cancer a549 cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human nonsmall cell lung cancer a549 cell line - by Bioz Stars, 2024-04
    86/100 stars

    Images

    nonsmall cell lung cancer a549  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    ATCC nonsmall cell lung cancer a549
    Antiproliferative Activities of DHPs 5a – 5t <xref ref-type= a " width="250" height="auto" />
    Nonsmall Cell Lung Cancer A549, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonsmall cell lung cancer a549/product/ATCC
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nonsmall cell lung cancer a549 - by Bioz Stars, 2024-04
    93/100 stars

    Images

    1) Product Images from "Discovery of Dihydropyrrol-2-ones as Novel G0/G1-Phase Arresting Agents Inducing Apoptosis"

    Article Title: Discovery of Dihydropyrrol-2-ones as Novel G0/G1-Phase Arresting Agents Inducing Apoptosis

    Journal: ACS Omega

    doi: 10.1021/acsomega.9b02543

    Antiproliferative Activities of DHPs 5a – 5t <xref ref-type= a " title="Antiproliferative Activities of DHPs 5a–5ta" property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Antiproliferative Activities of DHPs 5a – 5t a

    Techniques Used:

    human nonsmall cell lung cancer a549 cells  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    ATCC human nonsmall cell lung cancer a549 cells
    Human Nonsmall Cell Lung Cancer A549 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nonsmall cell lung cancer a549 cells/product/ATCC
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human nonsmall cell lung cancer a549 cells - by Bioz Stars, 2024-04
    93/100 stars

    Images

    nonsmall cell lung cancer a549 atcc  (ATCC)


    Bioz Verified Symbol ATCC is a verified supplier
    Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    ATCC nonsmall cell lung cancer a549 atcc
    Nonsmall Cell Lung Cancer A549 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonsmall cell lung cancer a549 atcc/product/ATCC
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nonsmall cell lung cancer a549 atcc - by Bioz Stars, 2024-04
    93/100 stars

    Images

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99
    ATCC a549 nonsmall cell lung cancer cells line
    (a) Immunocytochemical staining and (b) protein level of EGFR expression in LO2 cells, HeLa cells, and <t>A549</t> cells. Scale bar = 50 µ m. (c) FL images of A549 cells after 4 h of incubation with free ICG, ICG-LPs, GE11-ICG-LPs, and GE11-ICG-LPs with free GE11 peptide or anti-EGFR antibody blocking. DAPI (blue) counterstains cell nuclei. Scale bar = 50 µ m. (d) The semiquantitative analysis of fluorescence intensity in (c) was determined by ‘Image J' software. Data are expressed as mean ± SD ( n = 3). (e) FL images of A549 cells incubated with GE11-CUR/ICG-LPs after laser irradiation (1 W·cm −2 ) for different times. Scale bar = 50 µ m.
    A549 Nonsmall Cell Lung Cancer Cells Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a549 nonsmall cell lung cancer cells line/product/ATCC
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    a549 nonsmall cell lung cancer cells line - by Bioz Stars, 2024-04
    99/100 stars
      Buy from Supplier

    86
    ATCC human nonsmall cell lung cancer cell line a549
    (a) Immunocytochemical staining and (b) protein level of EGFR expression in LO2 cells, HeLa cells, and <t>A549</t> cells. Scale bar = 50 µ m. (c) FL images of A549 cells after 4 h of incubation with free ICG, ICG-LPs, GE11-ICG-LPs, and GE11-ICG-LPs with free GE11 peptide or anti-EGFR antibody blocking. DAPI (blue) counterstains cell nuclei. Scale bar = 50 µ m. (d) The semiquantitative analysis of fluorescence intensity in (c) was determined by ‘Image J' software. Data are expressed as mean ± SD ( n = 3). (e) FL images of A549 cells incubated with GE11-CUR/ICG-LPs after laser irradiation (1 W·cm −2 ) for different times. Scale bar = 50 µ m.
    Human Nonsmall Cell Lung Cancer Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nonsmall cell lung cancer cell line a549/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human nonsmall cell lung cancer cell line a549 - by Bioz Stars, 2024-04
    86/100 stars
      Buy from Supplier

    93
    ATCC nonsmall cell lung cancer nsclc cell lines a549
    Enrichment of CSCs from <t>A549</t> and PC-9 cells. (A) After being cultured in a serum-free medium, spheres derived from A549 and PC-9 were imaged at an amplification of ×10. (B) By performing CCK-8 assay, the cell viability of CSCs and their parental cells from days 1 to 5 was measured. * p < 0.05 vs. the parental cell group. The mRNA (C) and protein levels (D) of stemness hallmarkers, including CD24, CD44, ALDH1, Nanog, Oct4, and Sox2 were measured by performing RT-qPCR and Western blot analysis. * p < 0.05 vs. parental cell group.
    Nonsmall Cell Lung Cancer Nsclc Cell Lines A549, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonsmall cell lung cancer nsclc cell lines a549/product/ATCC
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nonsmall cell lung cancer nsclc cell lines a549 - by Bioz Stars, 2024-04
    93/100 stars
      Buy from Supplier

    86
    ATCC human nonsmall cell lung cancer cell lines a549
    Enrichment of CSCs from <t>A549</t> and PC-9 cells. (A) After being cultured in a serum-free medium, spheres derived from A549 and PC-9 were imaged at an amplification of ×10. (B) By performing CCK-8 assay, the cell viability of CSCs and their parental cells from days 1 to 5 was measured. * p < 0.05 vs. the parental cell group. The mRNA (C) and protein levels (D) of stemness hallmarkers, including CD24, CD44, ALDH1, Nanog, Oct4, and Sox2 were measured by performing RT-qPCR and Western blot analysis. * p < 0.05 vs. parental cell group.
    Human Nonsmall Cell Lung Cancer Cell Lines A549, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nonsmall cell lung cancer cell lines a549/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human nonsmall cell lung cancer cell lines a549 - by Bioz Stars, 2024-04
    86/100 stars
      Buy from Supplier

    86
    ATCC human nonsmall cell lung cancer a549 cell line
    Enrichment of CSCs from <t>A549</t> and PC-9 cells. (A) After being cultured in a serum-free medium, spheres derived from A549 and PC-9 were imaged at an amplification of ×10. (B) By performing CCK-8 assay, the cell viability of CSCs and their parental cells from days 1 to 5 was measured. * p < 0.05 vs. the parental cell group. The mRNA (C) and protein levels (D) of stemness hallmarkers, including CD24, CD44, ALDH1, Nanog, Oct4, and Sox2 were measured by performing RT-qPCR and Western blot analysis. * p < 0.05 vs. parental cell group.
    Human Nonsmall Cell Lung Cancer A549 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nonsmall cell lung cancer a549 cell line/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human nonsmall cell lung cancer a549 cell line - by Bioz Stars, 2024-04
    86/100 stars
      Buy from Supplier

    93
    ATCC nonsmall cell lung cancer a549
    Antiproliferative Activities of DHPs 5a – 5t <xref ref-type= a " width="250" height="auto" />
    Nonsmall Cell Lung Cancer A549, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonsmall cell lung cancer a549/product/ATCC
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nonsmall cell lung cancer a549 - by Bioz Stars, 2024-04
    93/100 stars
      Buy from Supplier

    93
    ATCC human nonsmall cell lung cancer a549 cells
    Antiproliferative Activities of DHPs 5a – 5t <xref ref-type= a " width="250" height="auto" />
    Human Nonsmall Cell Lung Cancer A549 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human nonsmall cell lung cancer a549 cells/product/ATCC
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human nonsmall cell lung cancer a549 cells - by Bioz Stars, 2024-04
    93/100 stars
      Buy from Supplier

    93
    ATCC nonsmall cell lung cancer a549 atcc
    Antiproliferative Activities of DHPs 5a – 5t <xref ref-type= a " width="250" height="auto" />
    Nonsmall Cell Lung Cancer A549 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nonsmall cell lung cancer a549 atcc/product/ATCC
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    nonsmall cell lung cancer a549 atcc - by Bioz Stars, 2024-04
    93/100 stars
      Buy from Supplier

    Image Search Results


    (a) Immunocytochemical staining and (b) protein level of EGFR expression in LO2 cells, HeLa cells, and A549 cells. Scale bar = 50 µ m. (c) FL images of A549 cells after 4 h of incubation with free ICG, ICG-LPs, GE11-ICG-LPs, and GE11-ICG-LPs with free GE11 peptide or anti-EGFR antibody blocking. DAPI (blue) counterstains cell nuclei. Scale bar = 50 µ m. (d) The semiquantitative analysis of fluorescence intensity in (c) was determined by ‘Image J' software. Data are expressed as mean ± SD ( n = 3). (e) FL images of A549 cells incubated with GE11-CUR/ICG-LPs after laser irradiation (1 W·cm −2 ) for different times. Scale bar = 50 µ m.

    Journal: Bioinorganic Chemistry and Applications

    Article Title: GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy

    doi: 10.1155/2021/5534870

    Figure Lengend Snippet: (a) Immunocytochemical staining and (b) protein level of EGFR expression in LO2 cells, HeLa cells, and A549 cells. Scale bar = 50 µ m. (c) FL images of A549 cells after 4 h of incubation with free ICG, ICG-LPs, GE11-ICG-LPs, and GE11-ICG-LPs with free GE11 peptide or anti-EGFR antibody blocking. DAPI (blue) counterstains cell nuclei. Scale bar = 50 µ m. (d) The semiquantitative analysis of fluorescence intensity in (c) was determined by ‘Image J' software. Data are expressed as mean ± SD ( n = 3). (e) FL images of A549 cells incubated with GE11-CUR/ICG-LPs after laser irradiation (1 W·cm −2 ) for different times. Scale bar = 50 µ m.

    Article Snippet: A549 nonsmall cell lung cancer cells line, HeLa human cervical cancer cell and LO2 human normal liver cells were purchased from American Type Culture Collection (ATCC, USA).

    Techniques: Staining, Expressing, Incubation, Blocking Assay, Fluorescence, Software, Irradiation

    (a), (b) Cytotoxicity and phototoxicity of free CUR/ICG, CUR/ICG-LPs and GE11-CUR/ICG-LPs under the NIR laser irradiation (808 nm) of 1 W·cm −2 for 5 min at different concentrations on A549 cells after 24 h incubation. (c) Fluorescence images of A549 cells stained with calcein-AM (green) after different treatments. Scale bar = 100 μ m. (d) Synergistic effect of photo- and chemotherapy based on GE11-CUR/ICG-LPs. Cytotoxicity of GE11-ICG-LPs, GE11-CUR-LPs, and GE11-CUR/ICG-LPs with or without laser exposure was performed by MTT assays. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.

    Journal: Bioinorganic Chemistry and Applications

    Article Title: GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy

    doi: 10.1155/2021/5534870

    Figure Lengend Snippet: (a), (b) Cytotoxicity and phototoxicity of free CUR/ICG, CUR/ICG-LPs and GE11-CUR/ICG-LPs under the NIR laser irradiation (808 nm) of 1 W·cm −2 for 5 min at different concentrations on A549 cells after 24 h incubation. (c) Fluorescence images of A549 cells stained with calcein-AM (green) after different treatments. Scale bar = 100 μ m. (d) Synergistic effect of photo- and chemotherapy based on GE11-CUR/ICG-LPs. Cytotoxicity of GE11-ICG-LPs, GE11-CUR-LPs, and GE11-CUR/ICG-LPs with or without laser exposure was performed by MTT assays. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.

    Article Snippet: A549 nonsmall cell lung cancer cells line, HeLa human cervical cancer cell and LO2 human normal liver cells were purchased from American Type Culture Collection (ATCC, USA).

    Techniques: Irradiation, Incubation, Fluorescence, Staining

    (a) Effects of IC-GLPs on the caspase-3 activity in A549 cells, data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001. (b) Intracellular ROS detection by the DCFH-DA fluorescence staining. Scale bar = 50 μ m. (c) Cytoskeletal microtubulin (red) expression in A549 cells after different treatments with laser irradiation. DAPI (blue) counterstains cell nuclei. Scale bar = 10 μ m.

    Journal: Bioinorganic Chemistry and Applications

    Article Title: GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy

    doi: 10.1155/2021/5534870

    Figure Lengend Snippet: (a) Effects of IC-GLPs on the caspase-3 activity in A549 cells, data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001. (b) Intracellular ROS detection by the DCFH-DA fluorescence staining. Scale bar = 50 μ m. (c) Cytoskeletal microtubulin (red) expression in A549 cells after different treatments with laser irradiation. DAPI (blue) counterstains cell nuclei. Scale bar = 10 μ m.

    Article Snippet: A549 nonsmall cell lung cancer cells line, HeLa human cervical cancer cell and LO2 human normal liver cells were purchased from American Type Culture Collection (ATCC, USA).

    Techniques: Activity Assay, Fluorescence, Staining, Expressing, Irradiation

    (a) Representative western blot and (b) quantification of Bcl-2 and Bax expression in A549 cells following treatment with PBS, free CUR/ICG, CUR/ICG-LPs, and GE11-CUR/ICG-LPs under 808 nm laser irradiation for 5 min. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05 and ∗∗ P < 0.01. (c) Representative western blot and (d) quantification of PI3K, p-PI3K, Akt, and p-Akt expression in A549 cells following different treatments with laser irradiation. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.

    Journal: Bioinorganic Chemistry and Applications

    Article Title: GE11 Peptide Conjugated Liposomes for EGFR-Targeted and Chemophotothermal Combined Anticancer Therapy

    doi: 10.1155/2021/5534870

    Figure Lengend Snippet: (a) Representative western blot and (b) quantification of Bcl-2 and Bax expression in A549 cells following treatment with PBS, free CUR/ICG, CUR/ICG-LPs, and GE11-CUR/ICG-LPs under 808 nm laser irradiation for 5 min. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05 and ∗∗ P < 0.01. (c) Representative western blot and (d) quantification of PI3K, p-PI3K, Akt, and p-Akt expression in A549 cells following different treatments with laser irradiation. Data are expressed as mean ± SD ( n = 3). ∗ P < 0.05, ∗∗ P < 0.01 and ∗∗∗ P < 0.001.

    Article Snippet: A549 nonsmall cell lung cancer cells line, HeLa human cervical cancer cell and LO2 human normal liver cells were purchased from American Type Culture Collection (ATCC, USA).

    Techniques: Western Blot, Expressing, Irradiation

    Enrichment of CSCs from A549 and PC-9 cells. (A) After being cultured in a serum-free medium, spheres derived from A549 and PC-9 were imaged at an amplification of ×10. (B) By performing CCK-8 assay, the cell viability of CSCs and their parental cells from days 1 to 5 was measured. * p < 0.05 vs. the parental cell group. The mRNA (C) and protein levels (D) of stemness hallmarkers, including CD24, CD44, ALDH1, Nanog, Oct4, and Sox2 were measured by performing RT-qPCR and Western blot analysis. * p < 0.05 vs. parental cell group.

    Journal: Frontiers in Oncology

    Article Title: RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53

    doi: 10.3389/fonc.2022.858694

    Figure Lengend Snippet: Enrichment of CSCs from A549 and PC-9 cells. (A) After being cultured in a serum-free medium, spheres derived from A549 and PC-9 were imaged at an amplification of ×10. (B) By performing CCK-8 assay, the cell viability of CSCs and their parental cells from days 1 to 5 was measured. * p < 0.05 vs. the parental cell group. The mRNA (C) and protein levels (D) of stemness hallmarkers, including CD24, CD44, ALDH1, Nanog, Oct4, and Sox2 were measured by performing RT-qPCR and Western blot analysis. * p < 0.05 vs. parental cell group.

    Article Snippet: Nonsmall cell lung cancer (NSCLC) cell lines A549 and PC-9 were all purchased from the American Type Culture Collection (ATCC).

    Techniques: Cell Culture, Derivative Assay, Amplification, CCK-8 Assay, Quantitative RT-PCR, Western Blot

    CSCs present a relatively lower m 6 A methylation level compared with their parental cells. (A) Global m 6 A methylation was measured in CSCs and its parental cells of A549 and PC-9. * p < 0.05 vs. parental cells. m 6 A methylation-relative gene expressions including METLL3, METLL14, YTHDF1, WTAP, FTO, and ALKBH5 were measured in mRNA (B) and protein levels (C) . (D) By employing the GEPIA database analysis tool, the relative mRNA levels of METLL3, METLL14, YTHDF1, WTAP, FTO, and ALKBH5 were compared between tumor samples and nontumor samples.

    Journal: Frontiers in Oncology

    Article Title: RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53

    doi: 10.3389/fonc.2022.858694

    Figure Lengend Snippet: CSCs present a relatively lower m 6 A methylation level compared with their parental cells. (A) Global m 6 A methylation was measured in CSCs and its parental cells of A549 and PC-9. * p < 0.05 vs. parental cells. m 6 A methylation-relative gene expressions including METLL3, METLL14, YTHDF1, WTAP, FTO, and ALKBH5 were measured in mRNA (B) and protein levels (C) . (D) By employing the GEPIA database analysis tool, the relative mRNA levels of METLL3, METLL14, YTHDF1, WTAP, FTO, and ALKBH5 were compared between tumor samples and nontumor samples.

    Article Snippet: Nonsmall cell lung cancer (NSCLC) cell lines A549 and PC-9 were all purchased from the American Type Culture Collection (ATCC).

    Techniques: Methylation

    p53 transcriptionally regulates ALKBH5 and subsequently decreased m 6 A methylation. (A) GEPIA database analysis tool was used to compare the correlation between ALKBH5 and p53 in LUAD and LUSC. (B) In A549 and PC-9 CSCs, the efficiency of p53 knockdown or overexpression was measured by performing a Western blot analysis. (C) After modification of p53 with or without PFT-α, ALKBH5 mRNA and protein level were measured. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. p53 group. (D) After modification of p53 with or without PFT-α, m 6 A methylation level was measured. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05, vs. vector group; # p < 0.05 vs. p53 group (right panel).

    Journal: Frontiers in Oncology

    Article Title: RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53

    doi: 10.3389/fonc.2022.858694

    Figure Lengend Snippet: p53 transcriptionally regulates ALKBH5 and subsequently decreased m 6 A methylation. (A) GEPIA database analysis tool was used to compare the correlation between ALKBH5 and p53 in LUAD and LUSC. (B) In A549 and PC-9 CSCs, the efficiency of p53 knockdown or overexpression was measured by performing a Western blot analysis. (C) After modification of p53 with or without PFT-α, ALKBH5 mRNA and protein level were measured. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. p53 group. (D) After modification of p53 with or without PFT-α, m 6 A methylation level was measured. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05, vs. vector group; # p < 0.05 vs. p53 group (right panel).

    Article Snippet: Nonsmall cell lung cancer (NSCLC) cell lines A549 and PC-9 were all purchased from the American Type Culture Collection (ATCC).

    Techniques: Methylation, Over Expression, Western Blot, Modification, Plasmid Preparation

    p53 inhibits malignancies via exerting transcriptional activity. In A549 CSCs, p53 was efficiently knockdown by transfecting shRNA targeting to p53 mRNA. In PC-9 CSCs, p53 was efficiently overexpressed by transfecting p53-coding plasmid. Cell viability was then analyzed by performing CCK-8 assay (A) . * p < 0.05 vs. shScrambled group (left panel); * p < 0.05 vs. vector group (right panel). (B) Cell cycle distribution was analyzed by performing PI staining followed by flow cytometry assay. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel). (C) Cell invasion was analyzed by performing Transwell assay. * p <0.05 vs. shScrambled group; # p < 0.05, vs. shp53 group (left panel); * p < 0.05, vs. vector group; # p < 0.05 vs. p53 group (right panel). (D) Tumor formation in soft agar was performed. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel).

    Journal: Frontiers in Oncology

    Article Title: RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53

    doi: 10.3389/fonc.2022.858694

    Figure Lengend Snippet: p53 inhibits malignancies via exerting transcriptional activity. In A549 CSCs, p53 was efficiently knockdown by transfecting shRNA targeting to p53 mRNA. In PC-9 CSCs, p53 was efficiently overexpressed by transfecting p53-coding plasmid. Cell viability was then analyzed by performing CCK-8 assay (A) . * p < 0.05 vs. shScrambled group (left panel); * p < 0.05 vs. vector group (right panel). (B) Cell cycle distribution was analyzed by performing PI staining followed by flow cytometry assay. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel). (C) Cell invasion was analyzed by performing Transwell assay. * p <0.05 vs. shScrambled group; # p < 0.05, vs. shp53 group (left panel); * p < 0.05, vs. vector group; # p < 0.05 vs. p53 group (right panel). (D) Tumor formation in soft agar was performed. * p < 0.05 vs. shScrambled group; # p < 0.05 vs. shp53 group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel).

    Article Snippet: Nonsmall cell lung cancer (NSCLC) cell lines A549 and PC-9 were all purchased from the American Type Culture Collection (ATCC).

    Techniques: Activity Assay, shRNA, Plasmid Preparation, CCK-8 Assay, Staining, Flow Cytometry, Transwell Assay

    p53 potentially regulates PRRX1, Sox2, and E-cadherin via ALKBH5. In A549 CSCs, p53 was efficiently knockdown by transfecting shRNA targeting p53 mRNA. In PC-9 CSCs, p53 was efficiently overexpressed by transfecting p53-coding plasmid. mRNA (A) and protein (B) of PRRX1, Sox2, and E-cadherin were measured. * p < 0.05 shScrambled group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel).

    Journal: Frontiers in Oncology

    Article Title: RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53

    doi: 10.3389/fonc.2022.858694

    Figure Lengend Snippet: p53 potentially regulates PRRX1, Sox2, and E-cadherin via ALKBH5. In A549 CSCs, p53 was efficiently knockdown by transfecting shRNA targeting p53 mRNA. In PC-9 CSCs, p53 was efficiently overexpressed by transfecting p53-coding plasmid. mRNA (A) and protein (B) of PRRX1, Sox2, and E-cadherin were measured. * p < 0.05 shScrambled group (left panel); * p < 0.05 vs. vector group; # p < 0.05 vs. p53 group (right panel).

    Article Snippet: Nonsmall cell lung cancer (NSCLC) cell lines A549 and PC-9 were all purchased from the American Type Culture Collection (ATCC).

    Techniques: shRNA, Plasmid Preparation

    Antiproliferative Activities of DHPs 5a – 5t <xref ref-type= a " width="100%" height="100%">

    Journal: ACS Omega

    Article Title: Discovery of Dihydropyrrol-2-ones as Novel G0/G1-Phase Arresting Agents Inducing Apoptosis

    doi: 10.1021/acsomega.9b02543

    Figure Lengend Snippet: Antiproliferative Activities of DHPs 5a – 5t a

    Article Snippet: The human breast cancer MCF-7, colon cancer RKO, cervical cancer HeLa, and nonsmall cell lung cancer A549 were obtained from American Type Culture Collection (ATCC).

    Techniques: